Menu

Seven More Retractions for Cancer Researcher

All of the papers had been published in the Journal of Biological Chemistry.

Aug 10, 2016
Kerry Grens

WIKIMEDIA, NATIONAL CANCER INSTITUTEBharat Aggarwal, a former investigator at MD Anderson Cancer Center, has racked up 18 retractions, seven of which were issued by the Journal of Biological Chemistry on August 5. As Retraction Watch reported, the latest retractions all have to do with image tampering.

Several of the retraction notices reference an investigation conducted by MD Anderson that revealed the improper image manipulations. In all of the suspect papers, images had been reused to represent different experimental conditions.

As Retraction Watch pointed out, Aggrawal had been held in high regard by the scientific community, and several papers he coauthored earned more than 1,000 citations apiece. The disgraced researcher now has another claim to fame: joining Retraction Watch’s list of most-retracted authors.  

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening